2023
Assessing Recommendations for Determining Fetal Risk in Alloimmunized Pregnancies in the United States: Is It Time to Update a Decades-Old Practice?
Abels E, Adkins B, Cedeno K, Booth G, Allen E, Stephens L, Woo J, Tormey C, Jacobs J. Assessing Recommendations for Determining Fetal Risk in Alloimmunized Pregnancies in the United States: Is It Time to Update a Decades-Old Practice? Transfusion Medicine Reviews 2023, 38: 150810. PMID: 38194730, DOI: 10.1016/j.tmrv.2023.150810.Peer-Reviewed Original ResearchAntigen testingEvidence-based recommendationsFetal risksAlloimmunized pregnanciesPoor outcomeHemolytic diseasePractice guidelinesDecades-old practiceNarrative reviewTransfusion medicineUnnecessary riskRecent evidencePregnancyUnited StatesFetusesRiskCurrent United StatesValuable alternativeTesting algorithmObstetriciansCurrent landscapeDiseaseRecommendations
2010
Evidence‐based practice guidelines for plasma transfusion
Roback JD, Caldwell S, Carson J, Davenport R, Drew MJ, Eder A, Fung M, Hamilton M, Hess JR, Luban N, Perkins JG, Sachais BS, Shander A, Silverman T, Snyder E, Tormey C, Waters J, Djulbegovic B. Evidence‐based practice guidelines for plasma transfusion. Transfusion 2010, 50: 1227-1239. PMID: 20345562, DOI: 10.1111/j.1537-2995.2010.02632.x.Peer-Reviewed Original ResearchConceptsTransfusion of plasmaPlasma transfusionCommon clinical scenariosMassive transfusionEvidence-based guidanceSystematic reviewIntracranial hemorrhageTransfusion decisionsPractice guidelinesClinical scenariosRed blood cell ratioEvidence-based practice guidelinesMultidisciplinary guideline panelPlasma transfusion guidelinesBlood cell ratioGroup of patientsClinical practice guidelinesAppropriate transfusionTransfusion guidelinesWarfarin anticoagulationGRADE methodologyGuideline panelObservational studyTransfusionDefinitive guidelines